Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

154
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of corneal infections using a smartphone macro lens for synchronous telemedicine.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2026
Same author

Outcomes of allogeneic ocular surface stem cell transplantation.

Frontiers in ophthalmology·2026
Same author

Posterior Segment Risk Factors for Penetrating Keratoplasty Failure.

American journal of ophthalmology·2026
Same author

Current Practices, Evolving Techniques, and Immunologic Challenges in Living and Deceased Donor Limbal Stem Cell Transplantation.

American journal of ophthalmology·2026
Same author

Global Consensus on Keratoconus and Ectatic Diseases-Edition 2.

Cornea·2026
Same author

Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.

Cornea·2026
Same journal

Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

Survey of ophthalmology·2026
Same journal

Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

Survey of ophthalmology·2026
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

3.0K

Drug-induced corneal epithelial changes.

Michael B Raizman1, Pedram Hamrah1, Edward J Holland2

  • 1Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Survey of Ophthalmology
|November 29, 2016
PubMed
Summary
This summary is machine-generated.

Many drugs cause corneal changes like vortex keratopathy or haze due to phospholipid accumulation. Understanding these drug-induced corneal deposits aids management, often without altering therapy.

Keywords:
corneacornea verticillataepitheliumocular side effectsvortex keratopathywhorl keratopathy

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

961
Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

3.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

3.0K
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

961
Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

3.4K

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Cell Biology

Background:

  • Numerous pharmacologic agents can induce epithelial changes in the cornea.
  • Cationic amphiphilic drugs, common in many classes, possess structures facilitating cell membrane penetration and intracellular phospholipid accumulation.
  • This accumulation can manifest as specific corneal opacities, such as vortex keratopathy or diffuse haze.

Purpose of the Study:

  • To review the diverse range of drugs causing corneal epithelial changes.
  • To elucidate the various mechanisms underlying drug-induced corneal deposits.
  • To provide insights into managing patients with these ocular side effects.

Main Methods:

  • Literature review of pharmacologic agents and their ocular side effects.
  • Analysis of drug structures and their correlation with corneal epithelial deposition.
  • Examination of clinical presentations and visual outcomes associated with drug-induced corneal changes.

Main Results:

  • Cationic amphiphilic drugs often cause vortex keratopathy with minimal visual impact.
  • Antineoplastic agents may induce a diffuse corneal haze, potentially leading to dose-limiting visual disturbances.
  • Other drugs can result in crystalline epithelial precipitation requiring intervention.

Conclusions:

  • Understanding the mechanisms of drug-induced corneal deposits is crucial for effective patient management.
  • In most cases, therapeutic drug levels can be maintained, but visual impairment necessitates physician collaboration for dose optimization.
  • Close monitoring is essential, especially when drugs are linked to other ocular toxicities like optic neuropathy or retinopathy.